I-Mab
For the period ended Dec 31, 2023. Filed Apr 30, 2024.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2023 · Filed Apr 30, 2024
NBP$0.91+0.2%Stored close · as of Nov 6, 2026
Contents
ITEM 16B. CODE OF ETHICS
Our board of directors adopted a code of business conduct and ethics that applies to our directors, officers and employees in November 2019. We have posted a copy of our code of business conduct and ethics on our website at http://ir.i-mabbiopharma.com/.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.